Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation

NCT03230747 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03230747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2017
Completion date
August 20, 2026
Enrollment
72 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mitral disease, mitral regurgitation